CDD-2807 is a chemical compound which acts as a potent and selective inhibitor of serine/threonine-protein kinase 33 (STK33), with a IC50 of 9.2 nM. In animal studies it causes production of abnormal sperm with reduced motility, and it has been investigated as a potential male contraceptive drug.[1][2]

See also

References

  1. ^ Holdaway J, Georg GI (May 2024). "An emerging target for male contraception". Science. 384 (6698): 849–850. Bibcode:2024Sci...384..849H. doi:10.1126/science.adp6432. PMID 38781397.
  2. ^ Ku AF, Sharma KL, Ta HM, Sutton CM, Bohren KM, Wang Y, et al. (May 2024). "Reversible male contraception by targeted inhibition of serine/threonine kinase 33". Science. 384 (6698): 885–890. Bibcode:2024Sci...384..885K. doi:10.1126/science.adl2688. PMC 11842024. PMID 38781365.
Allikas: https://en.wikipedia.org/wiki/CDD-2807
No tags for this post.